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to study late side-effects, including secondary radiation-
induced cancers. Although a number of predictive models 
exist, the absolute accuracy of these models in the 
radiotherapy dose range is limited partly due to scarcity of 
data and partly by extrapolation beyond historical data 
bounds. One of the challenges faced with applying models to 
the highly spatially varying dose distributions produced in 
modern radiotherapy is dose heterogeneity within organs at 
risk. The aim of this work is to investigate the difference 
between using mean dose (MD) and high-resolution voxel-by-
voxel dose (VbV) maps for calculating malignant induction 
probability (MIP).  
Materials and Methods: A 3D conformal radiotherapy 
(3DCRT) and actively scanned proton plans were used for an 
adult patient and a teenage patient with medulloblastoma. 
MIP is calculated for each patient using the linear-quadratic 
(LQ), linear (LIN) and linear-no-threshold (LNT) models with 
in-house developed code. MIPs calculated using the mean 
dose to the organs as well as voxel-by-voxel dose are 
compared for individual organs and the whole body. 
Results: Whole body MIPMD for the adult patient ranged 
between 0.337 and 0.929, while MIPVbV ranged between 0.078 
and 0.929 with choice of model. MIPMD for the teenage 
patient ranged between 0.222 and 0.834, while MIPVbV ranged 
between 0.057 and 0.834 (Table 1).  
 
 
 
For the LNT model, where MIP is linear with dose, the MD and 
VbV results are identical, as expected. For the nonlinear LQ 
and LIN models, significant differences in MIP can be seen. 
Organ-specific MIPs vary over a wide range (Figure 1), 
although MIPMD is higher than MIPVbV by an average factor of 
1.7 (adult) and 1.6 (teenage) for both the LQ and LIN models 
for 3DCRT plans and an average factor of 3.1 (adult) and 2.3 
(teenage) for proton plans.  
 
 
 
Use of MD gives consistently higher MIP estimates than VbV 
calculation in areas of dose heterogeneity (note reversal of 
this trend in the brain, which has a uniform high dose).  
 
Conclusions: Results demonstrate large systematic 
differences between the risk estimates produced using either 
mean dose or voxel-by-voxel calculation. Although the 
relative relation between MIPPhoton and MIPProton remains 
broadly constant, using mean dose in heterogeneous dose 
distributions potentially overestimates MIP and, by 
association, secondary cancer risk.  
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Purpose/Objective: The linear quadratic (LQ) model is the 
basis of many radiobiological predictions. Its main 
parameters α and β represent the tissues’ radiosensitivity, 
whereas the ratio α/β represents the fractionation 
sensitivity. 
Generic values are often used for biological modelling (e.g. 
α/β = 10Gy), which may not be appropriate for all tumours. 
Many studies estimate the LQ-parameters from clinical data, 
but heterogeneity in patient populations and analysis 
methods leads to disagreement between their results, 
reflected in non-overlapping 95% confidence intervals (CIs). 
Moreover, all these studies group tumours by tumour site, 
though this might not be the most predictive factor for 
tumour biology. 
The purpose of this study is to determine reliable values and 
CIs for α, β and α/β for biological modelling and explore 
factors that best explain the aforementioned heterogeneity.  
Materials and Methods: A systematic search of the Medline 
database using PubMed was performed. Papers estimating α, 
β or α/β were included if their analysis was based on clinical 
data and if none of these parameters were kept fixed in the 
analysis. 
The best statistical model for the meta-analyses of α, β and 
α/β was determined by a stepwise procedure. Different 
random effect models were compared based on the finite 
sample size Akaike Information Criterion (AICc). Next, factors 
were investigated for heterogeneity using different 
univariable models. Significant factors were then combined 
in multivariable models and the best model (lowest AICc) was 
used for the final meta-analysis. Factors that were tested 
were the type of LQ model, TCP model, clinical endpoint, 
tumour site and histology. 
Results: Out of 1059 papers returned by the systematic 
search, 60 satisfied the selection criteria, reporting 65 
estimates of α and β and 135 of α/β. The best statistical 
model for α included only the type of LQ model as factor, 
while for β and α/β the combinations LQ model + histology 
and LQ model + site provided the best (equally good) models. 
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These models were used to estimate values for α, β and α/β 
(figure 1). 
Higher α and α/β values are reported when repopulation was 
included in the LQ model. Adenocarcinomas, gliomas and 
other non-carcinomas appear to have an α/β < 10Gy when 
parameters were estimated using the basic LQ model. 
Regarding tumour sites, the same holds for prostate, breast 
and central nervous system tumours. 
 
 
Figure 1. Meta-regression results for α by LQ model, β by LQ 
model + histology, β by LQ model + site, α/β by LQ model + 
histology and α/β by LQ model + site (left to right, top to 
bottom). 
 
Conclusions: The generic value of α/β = 10Gy often used in 
biological modelling does not seem to be appropriate for all 
tumours. The data presented here provide estimates for 
various tumour sites and histologies, based on the current 
evidence from the available literature.  
Tumour histology and tumour site are equally good predictors 
for β and α/β. Furthermore, when selecting an LQ model for 
radiobiological modelling, it is important that the applied 
parameter values were estimated using the same type of LQ 
model. 
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Purpose/Objective: Our cooperative research project within 
the European Metrology Research Programme aims at 
correlating ion track structure characteristics with the 
biological effects of radiation and develops measurement and 
simulation techniques for determining ion track structure on 
different length scales from about 2 nm (diameter of the DNA 
double helix) to about 10 µm (diameter of the cell nucleus). 
Within this framework, we investigate methods to translate 
track-structure derived quantities onto the macroscopic scale 
with the aim of integrating them into clinical treatment 
planning systems which simulate and optimize the prescribed 
dose for each individual patient. 
Materials and Methods: For this purpose, input data were 
generated by simulations of ion tracks in liquid water using 
the Geant4 Monte Carlo toolkit with the Geant4-DNA 
processes. Protons covering a clinically relevant energy range 
were started in the middle of a water cube (2 µm side 
length). Energy transfer points were recorded with 
nanometer resolution.  
We investigated parameterizations of overall properties of 
ion track structure that do not describe the track structure of 
each single track in detail but may be used to translate the 
broad distributions of track structure parameters in 
macroscopic volumes to biologically relevant mean values. 
One of these parameterizations links the energy of the 
projectile to the ionization pattern of the track using the 
distances to the 10 next neighbouring ionizations while 
another parameterization deals with ionization cluster size 
distributions. 
In the clinical situation we have to deal with a mixed 
radiation field where particles of various energies hit a voxel 
from several directions. In order to find macroscopic relevant 
mean values for this scenario, it is necessary to determine 
appropriate weighting methods for the identified 
parameterizations. 
Results: We show that a dose weighted mean value of the 
mentioned track structure properties is capable of describing 
the overall track structure in a cell exposed to a mixed 
radiation field. We also investigated the macroscopic 
scenario in which several cells in a voxel are exposed to a 
mixed radiation field. For doses typically present in a 
planning target volume we can provide a relevant mean value 
without undertaking detailed simulations. 
Conclusions: The parameterizations and appropriate 
weighting methods show a way how nanometric track 
structure properties could be integrated into a treatment 
planning system without the need to perform time consuming 
simulations on the nanometer level.  
This work was funded by an EMRP Researcher Excellence 
Grant. The EMRP is jointly funded by the EMRP participating 
countries within EURAMET and the European Union. 
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Purpose/Objective: The wide variety of complex modern 
radiotherapy techniques leads to a high degree of variability 
in the dose delivered to organs outside the primary 
treatment field. For example, non-coplanar, conformal 
accelerated partial breast irradiation (APBI) and simultaneous 
integrated boost (SIB) using intensity modulation give very 
different organ doses to standard whole breast radiotherapy. 
Planning systems calculate and display dose within the region 
